Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

11010	Companies
241230	Keywords
169784	Articles
129853	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 05/02/2024 at 12:30, 2 years 4 months ago

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q1 revenues of $167 million, GAAP net loss of $1.2 billion, and diluted EPS of $(3.07). Company prepares for RSV vaccine and Spikevax® 2024-2025 formula launches, with expected product sales of $4 billion in 2024

Moderna Inc. Net Loss RSV Vaccine Q1 Revenues Spikevax 2024-2025 Formula
BRIEF

published on 04/25/2024 at 13:05, 2 years 4 months ago

Moderna to Present Diverse Research Studies at ESCMID Global Congress

COVID-19 Vaccine Moderna Vaccine Research Influenza Vaccine ESCMID Congress
PRESS RELEASE

published on 04/25/2024 at 13:00, 2 years 4 months ago

Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Moderna, Inc. to present data on COVID-19, influenza, respiratory syncytial virus, and cytomegalovirus vaccines at ESCMID Global Congress in Barcelona, Spain

COVID-19 Moderna Inc. Barcelona Vaccines ESCMID Global Congress
BRIEF

published on 04/24/2024 at 14:05, 2 years 4 months ago

Moderna Collaborates with OpenAI to Enhance mRNA Medicines Using Advanced AI

Healthcare Innovation MRNA Technology Moderna OpenAI AI Collaboration
PRESS RELEASE

published on 04/24/2024 at 14:00, 2 years 4 months ago

Moderna and OpenAI Collaborate To Advance mRNA Medicine
Moderna and OpenAI collaborate to integrate generative AI tools, like ChatGPT Enterprise, into operations to enhance AI culture and augment employee roles for maximum impact on patients

Generative AI Machine Learning Moderna OpenAI ChatGPT Enterprise
BRIEF

published on 04/17/2024 at 13:05, 2 years 4 months ago

Moderna to Present Q1 2024 Financial Results in May

Financial Results Conference Call Webcast Moderna Q1 2024
PRESS RELEASE

published on 04/17/2024 at 13:00, 2 years 4 months ago

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Moderna, Inc. will host a live conference call to report Q1 2024 financial results and provide a corporate update. Moderna is a leader in mRNA medicine revolutionizing disease treatment

Financial Results Conference Call Corporate Update Moderna Inc. MRNA Medicine
BRIEF

published on 04/03/2024 at 17:05, 2 years 5 months ago

Moderna's mRNA Therapy for Propionic Acidemia Shows Promise in Early-Stage Trial

Gene Therapy Clinical Trial Moderna MRNA Therapy Propionic Acidemia
PRESS RELEASE

published on 04/03/2024 at 17:00, 2 years 5 months ago

Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Moderna, Inc. announced interim data for mRNA-3927 therapy for propionic acidemia published in Nature, showing signs of clinical benefit and safety. Ongoing global trial evaluates safety and efficacy in participants with PA

Clinical Trial Moderna Propionic Acidemia MRNA-3927 Genetic Disorder
BRIEF

published on 03/27/2024 at 11:35, 2 years 5 months ago

Moderna Announces Significant Advancements in Vaccine Development Programs

COVID-19 MRNA Technology Moderna Vaccine Development Phase 3 Clinical Trials

Accesswire

Published on 09/17/2026 at 10:00, 1 hour 51 minutes ago

Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/16/2026 at 23:45, 12 hours 6 minutes ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 14 hours 21 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 18 hours 56 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 20 hours 51 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 11:30, 21 minutes ago

EyeROV: Indian Deep-Tech Startup Showcases its Underwater Drones to World Leaders
Published on 09/17/2026 at 11:30, 21 minutes ago

hep global reorganizes its management
Published on 09/17/2026 at 11:00, 51 minutes ago

ABB Ltd: ABB share buybacks - September 10, 2026 - September 16, 2026
Published on 09/17/2026 at 10:41, 1 hour 10 minutes ago

elumeo SE successfully completes a cash capital increase
Published on 09/17/2026 at 10:40, 1 hour 11 minutes ago

Making the Most of Every Ray, Powering the Unpowered: 2026 Global Low-Carbon Industry Forum Explores Pathways to Bridge the Electricity Gap

Les Echos

Published on 09/16/2026 at 20:46, 15 hours 5 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 18 hours 6 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 18 hours 6 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 4 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 17 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE